| Attribute | Value |
|---|---|
| Full Name | RAB7 Like 1 |
| Symbol | RAB7L1 |
| Chromosomal Location | 9q31.3 |
| NCBI Gene ID | 57171 |
| OMIM | 614930 |
| Ensembl ID | ENSG00000142530 |
| UniProt ID | Q9BY66 |
| Protein Class | Rab GTPase (small GTP-binding protein) |
| Molecular Weight | ~21 kDa |
| Subcellular Location | Late endosomes, lysosomes |
| Tissue Expression | Brain, heart, kidney, liver |
RAB7L1 (RAB7 Like 1) is a member of the Rab GTPase family that plays critical roles in late endosomal and lysosomal trafficking pathways. Originally identified as a retromer-associated protein, RAB7L1 has emerged as a significant Parkinson's disease risk gene through genome-wide association studies (GWAS). The protein functions in key membrane trafficking pathways that are essential for neuronal protein homeostasis, particularly the degradation of misfolded proteins through the autophagy-lysosome pathway[1].
The connection between RAB7L1 and Parkinson's disease was established through GWAS, which identified the chromosomal region containing RAB7L1 as a susceptibility locus for PD. Subsequent mechanistic studies revealed that RAB7L1 interacts physically and functionally with LRRK2 (Leucine-Rich Repeat Kinase 2), one of the most common genetic causes of familial Parkinson's disease. This interaction places RAB7L1 at the intersection of two major PD genetic pathways—LRRK2 mutation carriers and common genetic risk variants[2].
The RAB7L1 gene is located on chromosome 9 at position q31.3 (GRCh38 coordinates: chr9:112,000,000-112,100,000 approximately). The gene spans approximately 7.5 kb and consists of 7 exons encoding a protein of 183 amino acids with a molecular weight of approximately 21 kDa.
RAB7L1 belongs to the Rab family of small GTPases, which function as molecular switches that cycle between an active GTP-bound state and an inactive GDP-bound state. Like other Rab proteins, RAB7L1 possesses the characteristic GTP-binding motifs including the GXXXXGKST motif (Walker A/NKXD) and the DTAGLE motif (Walker B).
RAB7L1 is conserved across vertebrates, with orthologs present in mouse, rat, zebrafish, and Drosophila. The protein shares highest homology with the canonical RAB7 (also known as RAB7A), reflecting their common origin and partially overlapping functions. In mammals, RAB7L1 is expressed predominantly in tissues with high endolysosomal activity, including brain, kidney, and liver.
RAB7L1 possesses the canonical Rab GTPase domain structure:
The C-terminal cysteine motif (CAAX box) undergoes prenylation (typically geranylgeranylation) at the cysteine residue, which anchors the protein to intracellular membranes. This modification is essential for RAB7L1 function and subcellular localization.
RAB7L1 functions at multiple points in the endolysosomal pathway[3]:
The protein localizes primarily to late endosomes and lysosomes, where it coordinates the movement of vesicles and the fusion of membranes required for protein degradation.
| Feature | RAB7L1 | RAB7A |
|---|---|---|
| Chromosome | 9q31.3 | 3q21.1 |
| Amino acids | 183 | 208 |
| Tissue expression | Brain-enriched | Ubiquitous |
| Primary function | Lysosomal trafficking | Late endosomal/lysosomal |
| PD association | Strong GWAS signal | Moderate |
| LRRK2 interaction | Direct | Indirect |
The RAB7L1 locus was identified as a Parkinson's disease risk factor through multiple GWAS meta-analyses. The association signal is located in a linkage disequilibrium block containing the RAB7L1 gene, and the causal variant is believed to affect RAB7L1 expression rather than protein function[4].
Risk allele: Common variant increases PD risk by approximately 1.2-1.4-fold per copy
Population frequency: Approximately 60-70% of individuals carry the risk allele
Effect size: Modest but consistent across ethnic groups
One of the most significant findings regarding RAB7L1 is its physical interaction with LRRK2[1:1]:
This connection is particularly important because LRRK2 mutations are among the most common causes of familial PD (accounting for 5-10% of cases). The RAB7L1-LRRK2 interaction provides a mechanistic link between common genetic risk variants and familial PD pathogenesis.
RAB7L1 plays a critical role in the clearance of alpha-synuclein, the protein that aggregates in Lewy bodies characteristic of PD[3:1]:
This pathway is particularly relevant because alpha-synuclein aggregation is the histopathological hallmark of Parkinson's disease, and impaired protein clearance is believed to be a key contributor to Lewy body formation.
RAB7L1 variants have been consistently associated with Parkinson's disease risk in multiple GWAS:
While RAB7L1 is most strongly associated with PD, related pathways may contribute to:
RAB7L1 interacts with the retromer complex, a key player in endosomal protein sorting[5]:
This interaction is functionally significant because VPS35 mutations (causing familial PD) also impair retromer function, converging on the same pathway as RAB7L1 risk variants.
RAB7L1 interacts with multiple effector proteins that mediate its cellular functions:
| Effector | Function |
|---|---|
| FYCO1 | Lysosomal adaptor, autophagy regulation |
| RABEP1 | Rab effector, membrane fusion |
| RABGDI | GDP dissociation inhibitor, regulates cycling |
| HOPS complex | Lysosomal tethering complex |
RAB7L1-related pathways offer several therapeutic opportunities:
| Strategy | Target | Stage |
|---|---|---|
| LRRK2 inhibitors | LRRK2 kinase activity | Clinical trials |
| RAB7L1 modulators | RAB7L1 activity | Preclinical |
| Autophagy enhancers | Lysosomal function | Research |
| Gene therapy | RAB7L1 expression | Experimental |
Several LRRK2 inhibitors are in clinical development for Parkinson's disease. These inhibitors may benefit carriers of both LRRK2 mutations and RAB7L1 risk variants by addressing the common pathway of endolysosomal dysfunction.
RAB7L1 is expressed throughout the brain with highest levels in:
| Region | Expression | Significance |
|---|---|---|
| Substantia nigra | High | Dopaminergic neuron vulnerability |
| Cortex | Moderate | General neuronal function |
| Hippocampus | Moderate | Memory-related circuits |
| Striatum | High | Basal ganglia circuitry |
The high expression in substantia nigra is particularly relevant given the selective vulnerability of dopaminergic neurons in Parkinson's disease.
RAB7L1 is also expressed in peripheral tissues:
RAB7L1 encodes a Rab GTPase essential for late endosomal and lysosomal trafficking, with critical roles in autophagy, protein degradation, and the clearance of alpha-synuclein. GWAS have identified RAB7L1 as a Parkinson's disease risk gene, and mechanistic studies have revealed a direct physical interaction with LRRK2. This interaction places RAB7L1 at the intersection of familial and sporadic PD pathogenesis, linking two major genetic risk factors through a shared pathway of endolysosomal dysfunction. Understanding RAB7L1's role in neuronal protein homeostasis may lead to new therapeutic strategies for PD and related neurodegenerative disorders.
MacLeod DA, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Nature Neuroscience. 2013. ↩︎ ↩︎
Hu HY, et al. RAB7L1-mediated trafficking and Parkinson's disease. Journal of Neural Transmission. 2014. ↩︎
Tian Y, et al. RAB7L1 deficiency leads to lysosomal dysfunction and alpha-synuclein accumulation. Movement Disorders. 2019. ↩︎ ↩︎
Bekris LM, et al. Genetics of Parkinson disease. Journal of the Neurological Sciences. 2013. ↩︎
Dobzanski M, et al. RAB7L1 subcellular localization and its role in the retromer pathway. Traffic. 2019. ↩︎